home / stock / arvn / arvn short
Short Information | Arvinas Inc. (NASDAQ:ARVN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,064,315 |
Total Actual Volume | 20,546,791 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 153,216 |
Average Short Percentage | 16.82% |
Is there a ARVN Short Squeeze or Breakout about to happen?
See the ARVN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $25.89 | $24.85 | $26.04 | $24.62 | 416,486 | 63,760 | 15.31% |
07-01-2024 | $26.62 | $25.98 | $26.805 | $25.841 | 765,898 | 121,978 | 15.93% |
06-28-2024 | $25.77 | $26.62 | $26.74 | $25.5 | 4,058,951 | 169,275 | 4.17% |
06-27-2024 | $25.83 | $25.85 | $26.1 | $25.08 | 1,081,702 | 230,624 | 21.32% |
06-26-2024 | $24.42 | $25.87 | $26.58 | $24.35 | 1,090,622 | 262,132 | 24.04% |
06-25-2024 | $24.98 | $24.46 | $24.985 | $23.7301 | 1,178,529 | 389,387 | 33.04% |
06-24-2024 | $25.25 | $24.97 | $25.59 | $24.64 | 542,002 | 91,440 | 16.87% |
06-21-2024 | $25.54 | $25.22 | $26.23 | $24.945 | 1,804,782 | 302,751 | 16.77% |
06-20-2024 | $24.51 | $25.3 | $25.35 | $24.01 | 790,497 | 197,528 | 24.99% |
06-18-2024 | $24.79 | $24.82 | $25.23 | $24.59 | 653,623 | 101,901 | 15.59% |
06-17-2024 | $25.51 | $24.94 | $25.6 | $24.49 | 744,893 | 208,314 | 27.97% |
06-14-2024 | $26.06 | $25.67 | $27.055 | $25.075 | 745,024 | 126,867 | 17.03% |
06-13-2024 | $26.41 | $26.45 | $26.84 | $25.65 | 787,969 | 74,289 | 9.43% |
06-12-2024 | $27.47 | $26.49 | $28.05 | $26.32 | 722,147 | 106,671 | 14.77% |
06-11-2024 | $26.76 | $26.29 | $27.1 | $26 | 575,178 | 112,050 | 19.48% |
06-10-2024 | $26.44 | $26.99 | $27.09 | $26.04 | 581,668 | 60,670 | 10.43% |
06-07-2024 | $27.13 | $26.69 | $27.71 | $26.21 | 544,156 | 91,720 | 16.86% |
06-06-2024 | $27.86 | $27.7 | $28.37 | $27.53 | 755,205 | 109,462 | 14.49% |
06-05-2024 | $29.45 | $27.93 | $30.12 | $27.51 | 1,593,496 | 146,765 | 9.21% |
06-04-2024 | $27.79 | $29.12 | $29.24 | $27.595 | 1,113,963 | 96,731 | 8.68% |
News, Short Squeeze, Breakout and More Instantly...
- Awards Mr. Saik an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) - NEW HAVEN, Conn., June 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ann...
– Preclinical data for ARV-393 presented at t he European Hematology Association 2024 Annual Congress showed anti-tumor activity in models of B-cell lymphoma – – Preclinical data presented at the Biennial International LRRK2 Meeting high...
NEW HAVEN, Conn., June 17, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced Ian Taylor, Ph.D. has been promoted to President of Research and Development and Angela Cacace, P...